SUMMARY:
In the form of answers to the most frequent questions the author reviews the present development of an antimeningococcal vaccine and describes the existing possibilities of vaccination. The article broaches the history of vaccine development, categories of antimeningococcal vaccines, their weaknesses and advantages. The author discusses the issue of a vaccine against meningococcus B, the difference between a polysacharide and conjugated vaccine, the vaccination strategy in the Czech Republic and in the world and briefly describes the antimeningococcal immunity of our population.